the sun malaysia ipaper logo 150x150
Thursday, July 2, 2026
28.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

French Prime Minister Francois Bayrou condemns EU-US trade deal as submission

PARIS: French Prime Minister Francois Bayrou has strongly criticised the newly struck trade deal between the European Union and the United States, labelling it a “dark day” and an act of “submission.”

The agreement, finalised on Sunday, has drawn sharp reactions from politicians across France.

“It is a dark day when an alliance of free peoples, united to affirm their values and defend their interests, resorts to submission,“ Bayrou stated in a post on X.

The deal, negotiated by US President Donald Trump and European Commission President Ursula von der Leyen, sets a baseline tariff of 15 percent on EU exports to the US.

French President Emmanuel Macron has yet to publicly respond, but opposition leaders have been vocal.

Jordan Bardella of the far-right National Rally called it a “commercial surrender of Europe,“ while Marine Le Pen described it as a “political, economic, and moral fiasco.”

Macron ally Pieyre-Alexandre Anglade criticised the deal as a “signal of weakness,“ urging efforts to reverse its effects.

Meanwhile, Philippe Latombe of Bayrou’s Democratic Movement expressed regret, calling it a “bad deal, except for Trump.”

The Socialist Party and far-left France Unbowed also condemned the agreement, with Jean-Luc Melenchon framing it as a choice between “non-submission to the US Empire and non-alignment.”

French Finance Minister Eric Lombard and Foreign Minister Jean-Noel Barrot will meet with key economic stakeholders on Wednesday to assess the deal’s impact. – AFP

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings